Global burden of COPD: risk factors, prevalence, and future trends.

By David M. Mannino, A. Buist. The Lancet, 2007

2,170 citations recorded by the source corpus.

Subfields: Physiology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/fb3231b4a6480e9719b272b24d0c4d08a943ad79

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Physiology

1. P. Barnes
2. W. Macnee
3. David M. Mannino
4. M. Sullman
5. P. Calverley
6. D. Parums

In Pulmonary and Respiratory Medicine

1. D. Parums
2. P. Barnes
3. P. Calverley
4. Jorgen Vestbo
5. Alvar Agusti
6. W. Macnee
7. Gary S. Collins
8. Bartolome Celli

Citations in the corpus

• Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990-2019: results from the Global Burden of Disease Study 2019 (2022, methodology): “4 28 The Global Burden of Disease project uses an estimation or modelling process, however, rather than reporting real data on the burden of COPD.”
• Persistent Systemic Inflammation is Associated with Poor Clinical Outcomes in COPD: A Novel Phenotype (2012, background): “Addressing this complexity is a key challenge for a better understanding and treatment of NCDs in general [2], and COPD in particular [12,13].”
• Genetic Epidemiology of COPD (COPDGene) Study Design (2010, neutral): “Both the number of affected individuals and the number of deaths from COPD are expected to increase as the population ages (3).”
• Immunology of asthma and chronic obstructive pulmonary disease (2008, background): “jpg" NDATA ITEM> ]> Asthma and chronic obstructive pulmonary disease (COPD) are both very common and their incidence is increasing globally, placing an increasing burden on health services in industrialized and developing countrie”
• Ageing and the epidemiology of multimorbidity (2014, background): “…are provided by the Latin American Project for the Investigation of Obstructive Lung Disease (PLATINO) (five countries in Latin America) and Burden of Obstructive Lung disease (BOLD) study (12 countries) also demonstrated a significant variation in prevalence ranging from 5–20% [16] (fig.”